NZM.F NOVOZYMES A/S SPONS.ADR 1

Basic Materials Chemicals Frankfurt Exchange
67.25 EUR
Close of Nov 12, 2026
44.01 64.00
Market cap
EUR 27.7B
P/E
40.8x
P/B
2.49x
ROE
6.6%
Dividend yield
1.45%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NZM.F undervalued?

Graham number
Price67.25
Graham value31.64
Premium112.5%

NZM.F trades 112.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NOVOZYMES A/S SPONS.ADR 1 fundamental analysis

No fundamental analysis for NOVOZYMES A/S SPONS.ADR 1 yet.

NOVOZYMES A/S SPONS.ADR 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NOVOZYMES A/S SPONS.ADR 1

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricult…

Full company profile